basimglurant

Introduction Basimglurant, also known by its developmental codes RG-7090 and RO-4917523, is an investigational drug that is being developed by Roche and Chugai Pharmaceutical. This compound acts as a negative allosteric modulator of the metabotropic glutamate receptor 5 (mGlu5), which is implicated in various neurological disorders. Currently, basimglurant is under investigation for its potential use…